FMP
InVivo Therapeutics Holdings Corp.
NVIV
NASDAQ
Inactive Equity
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.
0.321 USD
-0.1673 (-52.17%)
About
ceo
Dr. Richard M. Toselli M.D.
sector
Healthcare
industry
Biotechnology
website
https://www.invivotherapeutics.com
exchange
NASDAQ
Description
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.
CIK
0001292519
ISIN
US46186M6057
CUSIP
46186M605
Address
One Kendall Square
Phone
617 863 5500
Country
US
Employee
6
IPO Date
Nov 15, 2010
Key Executives
